ArticleCardiovascular diabetology2021

Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials.

Koutaro Yokote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.